Terazosin And Metabolic Energetics in Parkinson's Disease

Study acronym: TAME-PD:
StatusSuspended
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Nandakumar Narayanan to Ergun Y. Uc
  2. Trial status changed: Not Yet Recruiting → Suspended Sponsor's reason: Study not funded
    • Start date: Jul 1, 2026 to Jul 1, 2028
    • Study sites: 0 to 1
    • Publications: details revised at 7 of 7 entries
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study investigates if Terazosin can improve metabolism in PD.
Trial Details
NCT Number NCT07464028
Lead Sponsor Ergun Y. Uc
Conditions
(from sponsor)		 Parkinson's Disease (PD)
Related terms Parkinson Disease
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov